# Safety and Efficacy of Oxcarbazepine Monotherapy in Adults With Partial Seizures

> **NCT00275925** · PHASE4 · COMPLETED · sponsor: **Novartis** · enrollment: 80 (—)

## Conditions studied

- Epilepsy, Partial Seizures

## Interventions

- **DRUG:** Oxcarbazepine

## Key facts

- **NCT ID:** NCT00275925
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12
- **Primary completion:** —
- **Final completion:** 2007-03
- **Target enrollment:** 80 (—)
- **Last updated:** 2007-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00275925

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00275925, "Safety and Efficacy of Oxcarbazepine Monotherapy in Adults With Partial Seizures". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00275925. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*